Health Industry Faces Major Shifts Amid New Regulations and Market Dynamics
Published on: Feb. 4, 2026, 2:30 a.m. | Source: Devdiscourse
Current developments in the health industry include EU's advisory on cereulide toxin levels in baby formula leading to product recalls, Mankind Pharma's profit boost, and USDA's efforts to control screwworms. Other highlights include delays in gender surgery recommendations and mixed results for Sanofi's experimental drug. Meanwhile, obesity drug markets face challenges.
